| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/25/1996 | US5530101 Humanized immunoglobulins |
| 06/25/1996 | US5530098 Human B-cell differentiation factor and process of producing said factor |
| 06/25/1996 | US5530094 Gamma retinoic acid receptor |
| 06/25/1996 | US5529925 Isolated nucleic acid molecule having sequence encoding anaplastic lymphoma kinase protein contained in plasmid |
| 06/25/1996 | US5529922 Anti-idiotypic monoclonal antibody that induces an immune response against the ganglioside GD3 and hybridoma producing said antibody |
| 06/25/1996 | US5529903 Extraction and cultivation of transformed cells and production of antibodies directed against them |
| 06/24/1996 | CA2163159A1 Penicillin v amidohydrolase gene from fusarium oxysporum |
| 06/20/1996 | WO1996018734A1 Production of recombinant secretory component |
| 06/20/1996 | WO1996018726A1 Compositions and methods for stimulating hematopoietic cell expansion |
| 06/20/1996 | WO1996018725A1 Human tissue inhibitor of metalloproteinase-4 |
| 06/20/1996 | WO1996018651A1 Human somatostatin-like receptor |
| 06/20/1996 | WO1996018650A1 Novel receptor |
| 06/20/1996 | WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection |
| 06/20/1996 | WO1996018641A1 Modulators of the function of fas/apo1 receptors |
| 06/20/1996 | WO1996018639A1 Novel protein tyrosine kinase, jak3 |
| 06/20/1996 | WO1996018414A1 Acellular anti-bordetella vaccine |
| 06/20/1996 | WO1996018412A1 Chimeric cytokines and uses thereof |
| 06/20/1996 | WO1996018409A1 In vivo activation of tumor-specific cytotoxic t cells |
| 06/20/1996 | WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 06/20/1996 | WO1996012397A3 Recombinant antibody capable of binding to pna/nucleic acid complexes |
| 06/20/1996 | CA2207921A1 Novel receptor |
| 06/20/1996 | CA2207736A1 In vivo activation of tumor-specific cytotoxic t cells |
| 06/20/1996 | CA2207626A1 Novel protein tyrosine kinase, jak3 |
| 06/20/1996 | CA2205572A1 Chimeric cytokines and uses thereof |
| 06/20/1996 | CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling |
| 06/19/1996 | EP0717109A1 Synthetic DNA derived recombinant HIV-2 antigens |
| 06/19/1996 | EP0717108A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
| 06/19/1996 | EP0717107A1 Transformant line of candida utilis yeast and expression of heterogene therewith |
| 06/19/1996 | EP0717104A2 Immunoassay of non-A, non-B hepatitis virus-related antigens, monoclonal antibodies for use therein, and hybridomas producing the antibodies |
| 06/19/1996 | EP0716710A1 Methods of suppressing immune response by gene therapy |
| 06/19/1996 | EP0716705A1 Method for the recombinant preparation of proteins in hansenula yeast |
| 06/19/1996 | EP0716704A1 MULTIPLE INTEGRATIVE VECTORS AND $i(YARROWIA LIPOLYTICA) TRANSFORMANTS |
| 06/19/1996 | EP0716700A1 Models of alzheimer's disease |
| 06/19/1996 | EP0716697A1 DIFFERENTIALLY EXPRESSED $i(LEISHMANIA) GENES AND PROTEINS |
| 06/19/1996 | EP0716696A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 06/19/1996 | EP0716695A1 Human calcium channel compositions and methods using them |
| 06/19/1996 | EP0716694A1 Human glucagon-like 1 peptide receptor |
| 06/19/1996 | EP0716692A1 Methods of suppressing autoimmune response |
| 06/19/1996 | EP0716691A1 Methods of suppressing graft rejection |
| 06/19/1996 | EP0716662A1 Dna encoding prostaglandin receptor ep2 |
| 06/19/1996 | EP0716660A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
| 06/19/1996 | EP0621899B1 Expression signal-peptide-free staphylokinases |
| 06/19/1996 | EP0527778B1 Improved process of purifying recombinant proteins and compounds useful in such process |
| 06/19/1996 | EP0524173B1 Solubilization and purification of the gastrin releasing peptide receptor |
| 06/19/1996 | EP0506923B1 A collagen binding protein as well as its preparation |
| 06/19/1996 | EP0495852B1 Modified biological material |
| 06/19/1996 | EP0452484B1 Production of proteins using homologous recombination |
| 06/19/1996 | EP0424397B1 Calcium channel compositions and methods |
| 06/19/1996 | CN1124928A Antibodies to P-selectin and their uses |
| 06/19/1996 | CN1124774A Variable region gene sequence of monoclonal antibody for resisting human activated blood platelet |
| 06/18/1996 | US5527896 Cloning by complementation and related processes |
| 06/18/1996 | US5527884 Mediators of chronic allograft rejection and DNA molecules encoding them |
| 06/18/1996 | US5527883 Delta-endotoxin expression in pseudomonas fluorescens |
| 06/18/1996 | US5527713 Consisting of t-cell specific antibodies covalently bound to amine groups present on water soluble aminodextran |
| 06/18/1996 | US5527703 Genetically engineered proteins for detection of channel modulators, insecticides, anthelmintics |
| 06/18/1996 | US5527700 Target antigens of transmission blocking antibodies for malaria parasites |
| 06/18/1996 | US5527690 Methods and compositions relating to sterol regulatory element binding proteins |
| 06/18/1996 | US5527668 Stable DNA constructs |
| 06/18/1996 | US5527555 Isolated from pentadiplandra brazzeana baillon |
| 06/18/1996 | CA2071954C Matrix with adherently bound cells and process for producing viruses/virus antigens |
| 06/18/1996 | CA2069741C Cloning cartridges and expression vectors in gram-negative bacteria |
| 06/18/1996 | CA2064754C Method of preparing polypeptides in a cell-free translation system |
| 06/18/1996 | CA2064685C Method of preparing polypeptides in a cell-free translation system |
| 06/18/1996 | CA1338401C Anticoagulant polypeptide |
| 06/13/1996 | WO1996017945A1 Reversible nuclear genetic system for male sterility in transgenic plants |
| 06/13/1996 | WO1996017942A1 Production of peptides using recombinant fusion protein constructs |
| 06/13/1996 | WO1996017941A2 Production of c-terminal amidated peptides from recombinant protein constructs |
| 06/13/1996 | WO1996017937A2 PESTICIDAL COMPOSITION COMPRISING CryIF CHIMERIC AND CryIA(c) CHIMERIC BACILLUS THURINGIENSIS DELTA-ENDOTOXIN |
| 06/13/1996 | WO1996017936A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
| 06/13/1996 | WO1996017935A2 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 06/13/1996 | WO1996017934A2 Cloning and recombinant production of crf receptor(s) |
| 06/13/1996 | WO1996017931A1 Human vascular ibp-like growth factor |
| 06/13/1996 | WO1996017925A1 Cytokine designated lerk-7 |
| 06/13/1996 | WO1996017924A2 Novel hedgehog-derived polypeptides |
| 06/13/1996 | WO1996017874A1 Monoclonal antibody fragments having immunosuppressant activity |
| 06/13/1996 | WO1996017868A1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 06/13/1996 | WO1996017866A1 Novel protein domain which binds tyrosine phosphorylated proteins |
| 06/13/1996 | WO1996017865A2 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 06/13/1996 | WO1996017625A1 Modulating the immune response |
| 06/13/1996 | WO1994026906A3 Cloned dna encoding a udp-galnac:polypeptide,n-acetylgalactos aminyltransferase |
| 06/13/1996 | CA2207262A1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 06/13/1996 | CA2207036A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 06/13/1996 | CA2207000A1 Modulating the immune response |
| 06/13/1996 | CA2206994A1 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 06/13/1996 | CA2206848A1 Production of peptides using recombinant fusion protein constructs |
| 06/13/1996 | CA2206664A1 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
| 06/13/1996 | CA2206488A1 Cytokine designated lerk-7 |
| 06/13/1996 | CA2206471A1 Monoclonal antibody fragments having immunosuppressant activity |
| 06/12/1996 | EP0716148A2 Recombinant alphavirus vectors |
| 06/12/1996 | EP0716146A2 A novel stem cell marker protein, antibodies thereto, compositions thereof and nucleotide sequences encoding said protein |
| 06/12/1996 | EP0716145A1 Improved steroid hormone superfamily receptors, and their use in screening and identifying potential antagonists |
| 06/12/1996 | EP0716095A1 Method for quantitative determination of fas antigen |
| 06/12/1996 | EP0716094A1 Process for purifying hepatitis B viral surface antigen comprising preS2 peptide |
| 06/12/1996 | EP0715653A1 Humanised antibodies |
| 06/12/1996 | EP0715633A1 Haemopoietic growth factor antagonists |
| 06/12/1996 | EP0538353B1 Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 06/12/1996 | EP0463151B1 Generation of xenogeneic antibodies |
| 06/12/1996 | EP0423201B1 Mhc-mediated conjugates useful in ameliorating autoimmunity |
| 06/12/1996 | EP0293471B1 Primary biliary cirrhosis autoantigen |
| 06/12/1996 | CN1124502A Mammal cell lines and method of obtaining glycoproteins |